N.L. Reinsmoen

Assessment of Tocilizumab (Anti–Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients

Jua Choi, O. Aubert, Ashley Vo et al. · American Journal of Transplantation · 2017 · 355 citations · Full text

Life Sciences, Immunology, Nephrology +17

Calculated PRA: Initial Results Show Benefits for Sensitized Patients and a Reduction in Positive Crossmatches

J. Michael Cecka, Anna Y. Kucheryavaya, N.L. Reinsmoen et al. · American Journal of Transplantation · 2010 · 166 citations

Life Sciences, Immunology, Allergy +4

Genetic Regulation of Rejection and Survival Following Human Lung Transplantation by the Innate Immune Receptor CD14

Walt Klimecki, Liheng Yu, N.L. Reinsmoen et al. · American Journal of Transplantation · 2007 · 72 citations · Full text

Life Sciences, Genetics, Immunology +17

Analysis of Subcutaneous (SQ) Alemtuzumab Induction Therapy in Highly Sensitized Patients Desensitized With IVIG and Rituximab

Ashley Vo, E.A. Wechsler, J. Wang et al. · American Journal of Transplantation · 2007 · 61 citations · Full text

Life Sciences, Immunology, Pharmacology +13

The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody-Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions

Patrick Bruneval, Annalisa Angelini, Dylan Miller et al. · American Journal of Transplantation · 2016 · 56 citations · Full text

Medicine, Immunology, Pathology +16